Introduction The Herpes Simplex Virus Treatment Market is witnessing steady growth as herpes simplex virus (HSV) infections continue to affect millions worldwide. Valued at USD 2.8 billion in 2024, the market is projected to reach USD 4.3 billion by 2034, expanding at a compound annual growth rate (CAGR) of 5.5%. HSV types 1 and 2 are the primary causes of oral and genital herpes...